
    
      This will be a double-blind, randomized, parallel-group, multicenter, dose-ranging study, in
      age >/= 65 years, and/or weight < 60 kg, and/or American Society of Anesthesiologists (ASA)
      Physical Classification Status 3 or 4 subjects using either the approved dose modification or
      1 lower dose, to achieve a moderate level of sedation required to complete the scheduled
      diagnostic or therapeutic procedure. Three subgroups of subjects will be included. For
      Subgroup 1 and Subgroup 2, approximately equal numbers of subjects will be enrolled into 2
      strata: weight >/= 55 kg and weight < 55 kg. For Subgroup 1 and Subgroup 2, subjects will be
      randomly assigned to 1 of 2 dose groups in a 1:1 ratio within each stratum. For Subgroup 3,
      subjects will be randomly assigned to 1 of 2 dose groups in a 1:1 ratio.
    
  